Eyepoint Pharmaceuticals Inc Cash Flow Reinvestment Rate
Eyepoint Pharmaceuticals Inc cash flow reinvestment rate. Eyepoint Pharmaceuticals Inc (EYPT) has a Cash Flow Reinvestment Rate of 0.25x as of June 2023, reinvesting $14.26 Million (capex $396.00K plus investments $13.86 Million) from operating cash flow of $57.02 Million. Explore Eyepoint Pharmaceuticals Inc cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of Eyepoint Pharmaceuticals Inc (2010–2023)
Cash flow reinvestment rate of Eyepoint Pharmaceuticals Inc from 2010 to 2023. Historical reinvestment intensity for Eyepoint Pharmaceuticals Inc across 3 annual periods. Explore EYPT capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
Eyepoint Pharmaceuticals Inc Cash Flow Reinvestment Rate by Year (2010–2023)
Eyepoint Pharmaceuticals Inc cash flow reinvestment rate by year from 2010 to 2023. Year-by-year capital reinvestment analysis for Eyepoint Pharmaceuticals Inc. For the full cash flow conversion analysis, see Eyepoint Pharmaceuticals Inc operating cash flow efficiency.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 3.63x | $6.80 Million | $1.88 Million | $3.48 Million | ▲ +727.8% |
| 2015 | 0.44x | $4.51 Million | $10.30 Million | $161.00K | ▲ +28804.5% |
| 2010 | 0.00x | $15.00K | $9.90 Million | $15.00K | — |